Immutep IMMP
NASDAQ IMMP
$3.14 -0.12 (-3.53%)
As of: Oct 22, 2026 · 3:29 PM EDT

Immutep (IMMP) EV to EBITDA (2016 - 2026)

Updated

Analysis

Immutep (IMMP) EV to EBITDA (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.71 Bn 1,136.29 Bn 19.71 Bn
2 Johnson & Johnson 647.75 Bn 567.61 Bn 17.30 Bn
3 AbbVie 503.60 Bn 476.71 Bn 12.70 Bn
4 Merck 368.10 Bn 322.48 Bn 12.21 Bn
5 Novartis Ag 303.19 Bn 267.18 Bn 11.24 Bn
6 Astrazeneca 268.04 Bn 241.73 Bn 12.86 Bn
7 Amgen 242.69 Bn 198.09 Bn 7.24 Bn
8 Gilead Sciences 194.89 Bn 169.09 Bn 6.22 Bn
9 Pfizer 173.31 Bn 119.95 Bn 10.94 Bn
10 Immutep 22.86 Mn -188.17 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.01
Jun 30, 2017 0.00
Mar 31, 2017 0.00
Jun 30, 2016 0.00
API Access

Immutep EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=IMMP&period=max&api_key=YOUR_API_KEY